| 英文别名 |
3-[2-[2-[2-[2-[[2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy;Pomalidomide-PEG4-COOH;2138440-81-8;3-[2-[2-[2-[2-[[2-(2,6-dioxo-3-piperidyl)-1,3-dioxo-isoindolin-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid;AT22727;Pomalidomide-PEG4-Acid;Pomalidomide 4'-PEG4-acid;MFCD32173789;Pomalidomide-PEG4-C2-acid;DA-56992;A1-49700;Pomalidomide-PEG4-CO2H;3-[2-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid;3-[2-[2-[2-[2-[[2-[(3S)-2,6-dioxo-3-piperidyl]-1,3-dioxo-isoindolin-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid;1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12-tetraoxapentadecan-15-oic acid;CS-0129693;SCHEMBL20242719;1-[[2-(2,6-Dioxo-3-piperidyl)-1,3-dioxo-4-isoindolinyl]amino]-3,6,9,12-tetraoxapentadecan-15-oic Acid;SY309954;MS-29668;2674167-61-2;HY-133699;Pomalidomide-PEG4-CH2CH2COOH;Pomalidomide-PEG4-COOH?;CHEMBL4789096;Crosslinker–E3 Ligase ligand conjugate;Partial PROTAC;Template for synthesis of targeted protein degrader |
微信公众号
客服
